论文期刊

取消

高级检索

检索历史清除

首页> Journal of the National Cancer Institute> Post-translational Regulation of Radioactive Iodine Therapy Response in Papillary Thyroid Carcinoma.

Post-translational Regulation of Radioactive Iodine Therapy Response in Papillary Thyroid Carcinoma.

导出原文传递

翻译打印收藏纠错

作者： Moran,Amit ^[1] ; Shorook,Na'ara ^[2] ; Demilza,Francis ^[2] ; Wisam,Matanis ^[2] ; Sagit,Zolotov ^[2] ; Birgit,Eisenhaber ^[2] ; Frank,Eisenhaber ^[3] ; Michal,Weiler Sagie ^[4] ; Leonid,Malkin ^[2] ; Salem,Billan ^[2] ; Tomer,Charas ^[2] ; Ziv,Gil ^[2]

作者单位： Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas. ^[1] The Laboratory for Applied Cancer Research, Department of Otolaryngology Head and Neck Surgery, The Head and Neck Center, Institute of Endocrinology, Nuclear Medicine Department, Pathology Department, and Radiotherapy Unit, Oncology Division, Rambam Healthcare Campus, Clinical Research Institute at Rambam, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel. ^[2] Bioinformatics Institute, Agency for Science, Technology and Research, Matrix, Singapore. ^[3] School of Computer Engineering, Nanyang Technological University, Singapore (FE); Department of Biological Sciences (DBS) and Computer Engineering (SCE), National University of Singapore (NUS); Singapore, Republic of Singapore. ^[4]

主题词酰基转移酶类(Acyltransferases);成年人(Adult);老年人(Aged);癌, 乳头状(Carcinoma, Papillary);病例对照研究(Case-Control Studies);女(雌)性(Female);糖基化(Glycosylation);人类(Humans);碘放射性同位素(Iodine Radioisotopes);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);蛋白质加工, 转译后(Protein Processing, Post-Translational);辐射耐受性(Radiation Tolerance);协同转运子(Symporters);甲状腺(Thyroid Gland);甲状腺肿瘤(Thyroid Neoplasms);青年人(Young Adult)

DOI 10.1093/jnci/djx092

PMID 30053080

发布时间 2019-02-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览16

Journal of the National Cancer Institute

Journal of the National Cancer Institute

2017年109卷12期

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷